Clinical manifestations
C. trachomatis causes trachoma, infant pneumonia, LGV and nongonococcal urethritis.
Although most infections caused by C. trachomatis in women are asymptomatic, clinical manifestations include cervicitis, urethritis, endometritis, Pelvic Inflammatory Disease (PID) or abscess of the Bartholin glands. 6 Although the initial site of infection is usually the cervix, the urethra and rectum may also be infected. 7 The prevalence of C. trachomatis infection in pregnant women ranges from 2 to 35%. 8 Pregnant women with chlamydial infections are at increased risk for adverse outcomes of pregnancy, and postpartum PID.
C. trachomatis is the most common cause of neonatal conjunctivitis and pneumonia in early infancy . 9 Fifteen to 25% of treated infants who were exposed at birth develop conjunctivitis, and 3 to 16% develop pneumonia . Symptoms of conjunctivitis usually develop within 2 weeks of delivery, and if the infection is untreated, chlamydial pneumonia can develop at 4 to 17 weeks after delivery . 10 These conditions are occasionally difficult to treat, and prolonged hospitalization may be necessary . Infants with chlamydial pneumonia are at increased risk for later pulmonary dysfunction and possibly for chronic respiratory disease . 11 Trachoma. Endemic trachoma is a chronic disease caused by repeated infections of the conjunctiva and cornea by C. trachomatis. Trachoma is probably the most common cause of preventable blindness worldwide. Epidemiologic studies of trachoma in developing countries have shown that this disease is most often due to infection by C. trachomatis serotypes A to C. Scarring of the conjunctiva with resultant trauma to the cornea appears to www.intechopen.com be due to repeated exposure to the chlamydial agent, which is transmitted primarily by nonsexual mechanisms. The ability to identify C. trachomatis from the conjunctivae of trachoma patients may vary greatly depending on the duration and clinical stage of the disease. 12 
Lymphogranuloma venereum (LGV)
LGV is a systemic disease caused by C. trachomatis serovars L1 to L3. The LGV serovars of C.trachomatis are more invasive than other genital serovars, resulting in infection of the epithelial layers and underlying soft tissue. 13 The primary symptom is a painless genital ulcer or papule. The most common manifestation of the secondary stage of LGV in men, and the reason most men seek treatment, is inflammation and swelling of the inguinal lymph nodes .Women tend to be less symptomatic at this stage: only 20 to 30% of women present with inguinal lymphadenopathy and approximately one-third of women without proctocolitis present with lower abdominal and back pain. 14 The secondary stage of infection is characterized by systemic symptoms including fever, malaise, chills, anorexia, myalgia, and arthralgia . 15 Untreated infections can lead to late complications including ulceration and hypertrophy of the genitalia, arthritis, and fistula formation involving the rectum, bladder, vagina, or vulva . 14 Nongonococcal urethritis. C. trachomatis serotypes D to K are the organisms most frequently associated with nongonococcal urethritis in men As many as one-third of men who harbor urethral Chlamydia may be asymptomatic In 1 to 2% of chlamydial urethral infections, infection can evolve to epididymitis. C. trachomatis is the most commonly isolated microorganism in young heterosexual men with epididymitis in whom there is no structural abnormality of the genitourinary disease. C. trachomatis infects the endocervix of women and may cause mucopurulent cervicitis. 8 This infection frequently spreads to the urethra and urinary bladder and may result in the "acute urethral syndrome"of abacteriuric pyuria . 12 Pneumonia Pneumonia and bronchitis are the most frequently recognized illnesses associated with C. pneumoniae, although asymptomatic infection or unrecognized, mildly symptomatic illnesses are the most common result of infection. In a series of studies 10% of cases of pneumonia and approximately 5% of bronchitis and sinusitis cases in adults have been attributed to the organism 16 .No set of symptoms or signs is unique to pulmonary infections with C. pneumoniae; however, several characteristics of the clinical presentation may help distinguish it from other causes . 17 A subacute onset is common. Pharyngitis, sometimes with hoarseness, is often present early in the course of the illness. There may be a biphasic pattern to the illness, with resolution of pharyngitis prior to development of a more typical bronchitis or pneumonia syndrome. Cough is very common and is often prolonged. 18, 19 Psittacosis. Reiter's classic description of respiratory disease associated with avian exposure (ornithosis, formerly "psittacosis") was the first modern recognition of C. psittaci disease . Both psittacine and nonpsittacine birds can harbor the infectious agent, and avian C. psittaci strains cause illness in bird handlers and poultry workers. Because of the antigenic diversity of C. psittaci, serologic methods based on detection of antibody responses to genus-specific antigens of chlamydiae are used for the presumptive diagnosis of ornithosis. Although C. psittaci can be isolated in cell culture or by animal inoculation with clinical specimens, the low sensitivity of these methods and the biohazard of C. psittaci in the laboratory have made serologic diagnosis the indicated laboratory method for diagnosis of ornithosis.
Mammalian. In spite of the broad range of non human hosts, zoonotic C. psittaci strains other than avian strains have infrequently been reported to cause human infection. A few cases of human infection resulting in abortion have been reported following infection by ovine C. psittaci strains .Rare cases of infective endocarditis presumed to be due to C. psittaci from avian and nonavian sources have also been reported. C. psittaci strains TWAR infections a novel group of chlamydial organisms has been associated with acute respiratory disease in humans. The acronym TWAR is derived from Taiwan-acute respiratory, the designations given to the first University of Washington studies that produced these strains. TWAR organisms have morphologic, antigenic, and developmental similarities to C. psittaci and are not inhibited in vitro by sulfonamides. Molecular studies of deoxyribonucleic acid relatedness suggest that TWAR agents are genetically homogeneous and differ from both C .psittaci and C. trachomatis. 20 
Epidemiology
Although C. trachomatis infection did not become a fully reportable disease in the United States until 1996, it is known to be the most common bacterial sexually transmitted disease (STD). The actual incidence of chlamydial infection is not yet known due to lack of reporting in all 50 states up to 1996; however, national trends have been estimated by using data from states that reported cases prior to 1996, sentinel surveillance, surveys, and models based on proxies of infection . 21, 22 Worldwide, it is estimated that there are more than 50 million new cases of C. trachomatis infection annually. 23 Although the major impact of disease caused by C. trachomatis is on the female reproductive tract, this agent also causes infections in men and children. 24 The prevalence of C. trachomatis infection in sexually active adolescent women, the population considered most at risk, generally exceeds 10%, and in some adolescent and STD clinic populations of women, the prevalence can reach 40%. 25 The prevalence of C.trachomatis infection ranges from 4 to 10% in asymptomatic men and from 15 to 20% in men attending STD clinics. 26, 27 Chlamydial infections in newborns occur as a result of perinatal exposure; approximately 65% of babies born from infected mothers become infected during vaginal delivery. 28 
Clinical sequelae of C. trachomatis infections in infants
C. trachomatis is the most common cause of neonatal conjunctivitis and one of the most common causes of pneumonia in early infancy. Prophylactic treatment of the eyes with silver nitrate does not prevent chlamydial infection; 15 to 25% of treated infants who were exposed at birth develop conjunctivitis, and 3 to 16% develop pneumonia. 29 Symptoms of conjunctivitis usually develop within 2 weeks of delivery and if the infection is untreated, chlamydial pneumonia can develop at 4 to 17 weeks after delivery. These conditions are occasionally difficult to treat, and prolonged hospitalization may be necessary. Infants with chlamydial pneumonia are at increased risk to develop pulmonary dysfunction and possibly chronic respiratory disease. 30 
Clinical sequelae of C. trachomatis infections in men
Among heterosexual men, chlamydial infections are usually urethral and up to 50% are asymptomatic 31 . When symptoms do occur, usually 1 to 3 weeks following exposure, they are indistinguishable from those of gonorrhea (urethral discharge and/or pyuria). However, compared with gonococcal urethritis, chlamydial urethritis is more likely to be asymptomatic. In older men, epididymitis is more often due to other etiologies associated with urinary tract abnormalities or instrumentation rather than sexually transmitted origins. 32 Unilateral scrotal pain is the primary symptom, and common clinical signs of this infection include scrotal swelling, tenderness, and fever. If urethral symptoms are also present, a sexually transmitted bacterial etiology is likely . 33 
Reitter's syndrome
Reitter's syndrome is caused by Chlamydia trachomatis The manifestations of reactive arthritis include the following triad of symptoms: an inflammatory arthritis of large joints including commonly the knee and the back (due to involvement of the sacroiliac joint), inflammation of the eyes in the form of conjunctivitis or uveitis, and urethritis in men or cervicitis in women. Patients can also present with mucocutaneous lesions, as well as psoriasis-like skin lesions such as circinate balanitis, and keratoderma blennorrhagica. Not all affected persons have all the manifestations, and the formal definition of the disease is the occurrence of otherwise unexplained non-infectious inflammatory arthritis combined with urethritis in men, or cervicitis in women. 34 Symptoms generally appear within 1-3 weeks but can range from 4 to 35 days from the onset of the inciting episode of the disease. The classical presentation is that the first symptom experienced is a urinary symptom such as burning pain on urination (dysuria) or an increased frequency of urination. Other urogenital problems may arise such as prostatitis in men and cervicitis, salpingitis and/or vulvovaginitis in women. 35 The arthritis that follows usually affects the large joints such as the knees causing pain and swelling with relative sparing of small joints such as the wrist and hand. Eye involvement occurs in about 50% of men with urogenital reactive arthritis and about 75% of men with enteric reactive arthritis. Conjunctivitis and uveitis can include redness of the eyes, eye pain and irritation, or blurred vision. 36 
Laboratory diagnosis of chlamydial infections
Specimens used for detecting Chlamydiae must be handled cautiously following universal precautions. Handling of specimens for the detection of C. psittaci r e q u i r e s t y p e I I I containment facility. The organism is air-borne and is highly virulent. 20 The most common anatomic site used to obtain specimens for the isolation of C. trachomatis from women is the endocervix, which is sampled with a swab (endocervix, Dacron and calcium alginate) or cytologic brush. The swab should be inserted into the cervical os past the squamocolumnar junction, about 1 to 2 cm deep, rotated for 15 to 30 s, and removed without touching the vaginal mucosa. 13 The transport medium may contain fetal calf serum up to 10% to preserve the viability of the organisms. The transport media may contain gentamycin or vancomycin , nystatin/ amphotericin B at a concentration of 10 microgram /ml to prevent the growth of other bacteria and fungi respectively while transport. Specimen upon receipt in the laboratory should be processed as early as possible. In case of delay the specimen can be stored for a maximum period of 48 hours in the refrigerator. If further delay is expected the specimen should be stored at -70 0 C until further processed. 37, 38 The earlier methods used for the direct detection include iodine staining which stains the glycogen present in the cell lines. Giemsa staining is applied to detect the inclusion bodies of the organism. Later mononclonal antibodies raised against the major outer membrane protein gene of the organism tagged with a Fluorecein Iso thiocyanate (FITC) dye . was widely used for the rapid detection of the agent from direct clinical specimens. 39 
Cultivation
Until recently, culture was considered the gold standard for detection of Chlamydia in specimens because it has a specificity that approaches 100% . The usual cell lines in use are HeLa 229, L434 mouse fibroblasts or McCoy cells in the case of C. trachomatis and C. psittaci; Buffalo green monkey kidney cells for C. psittaci and C. pecorum , HeLa or Hep2 cells for C. pneumoniae. The disadvantages of using culture as a gold standard include its relative insensitivity compared with DNA amplification techniques. 40 With the exception of 'fast growing' strains like the LGV biovar of C. trachomatis, it was usually necessary to assist the process of infection by centrifugation of the clinical material onto monolayers of the appropriate cells in tissue culture. Growth of the organisms was also facilitated by the use of anti-metabolites directed against the host cell (cycloheximide; emetine or mitomycin C) or, for the C. trachomatis TRIC: Trcahoma Inclusion conjunctivitis biovar, by the use of charged anionic polymers such as Poly -L -lysine or DEAE dextran. Compounds like polyethylene glycol or high energy glucose 6 phosphate also aided the growth of some chlamydiae. 41 
Rapid shell vial technique for cultivation
Modified culture technique where the cells are grown over cover slips placed inside a glass shell vial is used for the rapid cultivation of Chlamydia. Here the cells are grown over the www.intechopen.com cover slips and treated with cycloheximide (1microgram/ml) containing medium for 24 hours. 42 After the medium is aspirated out 200 micro liters of clinical specimen is added and the culture is centrifuged centrifuged at 3000 rpm for 1 hour. At the end of 1 hour, Dulbecco's minium essential medium with 10% fetal calf serum and 1-3 microgram cycloheximide is added and incubated at 37 O C (10 % CO 2 atmosphere) for 48-72 hours. At the end of incubation period the medium is aspirated out, the cover slip is fixed and stained with the antisera (Figure 2 ). This method is rapid and more sensitive in isolation of Chlamyida. 43 Since susceptibility of a cell line is an important factor for cultivation of C. trachomatis, Malathi et al 44 
Polymerase chain reaction (PCR) and Ligase chain reaction (LCR)
Plasmids of Chlamydia are known to exist in 7 copy numbers. Due to the rapidity, increased sensitivity and specificity PCR, LCR methods have widely replaced the conventional culture methods. 42, 43 The major target for amplification based tests against C. trachomatis are generally multiple-copy gene products, such as the cryptic chlamydial plasmid (Figure 3 ) or ribosomal RNA, Major outer membrane protein gene. Starting with a multiple copy gene offers a clear starting advantage with respect to sensitivity. The application of initial nucleic acid amplification based tests had increased the clinical sensitivity of detection of chlamydial DNA in clinical samples. 42, 45 The major advantage of nucleic acid based amplification technique is the combined sensitivity and specificity. Automation is possible and a large volume of sample can be handled at a time. The technique was helpful to establish the etiology of the C. pneumoniae in optic neuritis 46 where cultivation of the organism was not possible 
Screening tests for chlamydia
C. trachomatis infection is asymptomatic in 80% of women making diagnosis and detection difficult. Chlamydia has its high prevalence amongst young men and women and more than 13.5% of women < 25 years old have lower genital tract infections. 47 Screening women for lower genital tract infection with C. trachomatis is important in the prevention of PID, ectopic pregnancy and infertility. 48 The screening tests available for C. trachomatis include nucleic acid based amplification assays, PCR and LCR, gene probe and enzyme immuno assay. The sensitivity and specificity of Chlamydia trachomatis screening tests is provided in Table 4 Acute C. pneumoniae respiratory tract infections in previously unexposed, non asthmatic individuals can result in chronic asthma. Patients previously diagnosed with chronic asthma should be evaluated for possible chronic C. pneumoniae infection.
Chlamydial infections in pregnancy
Prematurity is one of the leading causes of perinatal mortality. Uterine contractions may be induced by cytokines, proteolytic enzymes or prostaglandins released or induced by microorganisms. Some studies 52, 53 suggest that maternal C. trachomatis infection in pregnancy is associated with premature delivery. Termination of pregnancy (i.e. induced abortion) is one of the most commonly performed gynecological procedures. Post-abortal PID is a well recognized complication of termination of pregnancy, with its attendant risks of tubal dysfunction and either infertility or subsequent ectopic pregnancy.
Prevention
Chlamydia prevention programs have been implemented to reduce the burden of reproductive sequelae resulting from chlamydial infection. Because most reproductive complications of Chlamydia occur in females and most infections are asymptomatic, the cornerstone of Chlamydia prevention is screening young females for infection. Nucleic acid amplification tests are the preferred diagnostic tests because of their superior sensitivity, and they can be performed on easily collected specimens, such as urine or vaginal swabs. 53 Highly efficacious treatment options include single-dose oral azithromycin or a 1-week course of doxycycline. National chlamydia screening recommendations were first released in 1993. Currently, CDC, the U.S. Preventive Services Task Force (USPSTF), and numerous professional medical associations recommend annual chlamydia screening for all sexually active females aged < 25 years and for females aged ≥ 25 years if they are at increased risk for infection (e.g., if they have new or multiple sex partners. 54 C. pneumoniae is difficult to prevent because it is spread by respiratory droplets from other sick people.Because people with this type of pneumonia do not always feel very sick, they often continue to attend school, go to work, and go to other public places. They then spread the bacteria in the tiny droplets that are released into the air during coughing. Therefore, this pneumonia is very difficult to prevent and often occurs in outbreaks within communities. 20 Prevention of C. trachomatis pneumonia involves recognizing the symptoms of genital infection in the mother and treating her prior to delivery of her baby. 53 
Prognosis of Chlamydia infection
The 'prognosis' of Chlamydia usually refers to the likely outcome of Chlamydia. The prognosis of Chlamydial infection may include the duration, chances of complications of Chlamydia infection , probable outcomes, prospects for recovery, recovery period for Chlamydia, survival rates, death rates, and other outcome possibilities in the overall prognosis of Chlamydia. Naturally, such forecast issues are by their nature unpredictable
The following are statistics from various sources about deaths related to Chlamydia:
Chlamydia death statistics for various regions worldwide: 
Chlamydial infection in children
Exposure to C. trachomatis during delivery can cause ophthalmia neonatorum (conjunctivitis) in neonates or chlamydial pneumonia at one to three months of age.
Ophthalmia neonatorum
Ophthalmia neonatorum usually occurs within five to 12 days of birth but can develop at any time up to one month of age. It may cause swelling in one or both eyes with mucopurulent drainage. Prophylaxis with silver nitrate or antimicrobial ointment, which reduces the risk of gonococcal infection in neonates, does not reduce the risk of chlamydial infection. Testing for chlamydial infection in neonates can be done by culture or nonculture techniques. The eyelid should be everted and the sample obtained from the inner aspect of the eyelid. Sampling the exudates is not adequate because this technique increases the risk of a false-negative test. Ophthalmia neonatorum can be treated with erythromycin base or ethylsuccinate at a dosage of 50 mg per kg per day orally, divided into four doses per day for 14 days. The cure rate for both options is only 80 percent, so a second course of therapy may be necessary. Topical treatment is ineffective for ophthalmia neonatorum and should not be used even in conjunction with systemic treatment. 53 
Chlamydial pneumonia
Acute lower respiratory tract infection (ALRTI) is the major cause of morbidity and mortality in young children world wide.Chlamydia pneumoniae is a common respiratory pathogen which is responsible for about 10% of community acquired pneumonia (CAP C. trachomatis exists as multiple serovariants that exhibit distinct organo tropism for the eye or urogenital tract. The genome of an oculotropic trachoma isolate (A/HAR-13) was sequenced and compared to the genome of a genitotropic (D/UW-3) isolate. Remarkably, the genomes share 99.6% identity, supporting the conclusion that a functional tryptophan synthase enzyme and toxin might be the principal virulence factors underlying disease organotropism. Tarp (translocated actin-recruiting phosphoprotein) was identified to have variable numbers of repeat units within the N and C portions of the protein. A correlation exists between lymphogranuloma venereum serovars and the number of N-terminal repeats. Single-nucleotide polymorphism (SNP) analysis between the two genomes highlighted the minimal genetic variation. A disproportionate number of SNPs were observed within some members of the polymorphic membrane protein (pmp) autotransporter gene family that corresponded to predicted T-cell epitopes that bind HLA class I and II alleles. These results implicate Pmps as novel immune targets, which could advance future chlamydial vaccine strategies. Lastly, a novel target CTA0934 for PCR diagnostics was discovered that can discriminate between ocular and genital strains. This discovery will enhance epidemiological investigations in nations where both trachoma and chlamydial STD are endemic. The results suggest that Tarp is among the few genes to play a role in adaptations to specific niches in the host. 58 
Chlamydial L,L -diaminopimelate aminotransferase
Recent phylogenetic studies have revealed that chlamydia shares a common ancestor with modern plants and retains unusual plant-like traits (both genetically and physiologically). In particular, the enzyme L,L-diaminopimelate aminotransferase, which is related to lysine production in plants, is also linked with the construction of chlamydia's cell wall. The genetic encoding for the enzymes is remarkably similar in plants and chlamydia, demonstrating a close common ancestry. 59 This unexpected discovery may help scientists develop new treatment avenues: if scientists could find a safe and effective inhibitor of L,Ldiaminopimelate aminotransferase, they might have a highly effective and extremely specific new antibiotic against chlamydia.
Emerging Chlamydial infections
Several Chlamydial like bacteria have recently been identified as potential emerging public threats or pathogenic agents in animals. Parachlamydia acanthamoebae, Parachalmydia naegelerophila and Simkania negerensis have been reported as possible aetiological agents of pneumonia in humans. To define further the possible pathogenetic potential of these Chlamydia like bacteria new diagnostic tools are needed to demonstrate the agent within tissue lesions. 60 Borel et al 60 have used tissue microarray technology to establish the immuno histochemistry protocols and to determine the specificity of new antisera against various Chlamydia like bacteria for future use on formalin fixed and paraffin embedded tissues. The antisera exhibited strong reactivity against autologous antigen and closely related heterologous antigen but no cross reactivity with distantly related species.
